RFP QuestBeta
ClosedStage · contract

MINISTRY OF DEFENCE

Medicine Management: An Investigation of Fentanyl Heat Expiry Following Exposure to Extreme Temperatures on Military Deployment

R&DCPV 73000000
Value£19k
Deadline27 Jun 2025
Published8 Jul 2025
RegionLondon
Timeline
Published 8 Jul 2025ClosedCloses 27 Jun 2025
Contract value in context
£19ktotal contract value
median £66k
this tender£0£561k

This sits below the typical range for Research & Development contracts — a smaller, more accessible award. Based on 20,405 valued Research & Development tenders in our corpus.

Match for your company
Sign up free to see how well this tender matches your company — the score, the signals that align, and where the gaps are.
The brief

This study aims to investigate the stability of Oral transmucosal fentanyl citrate (OTFC) lozenges following exposure to real-world environmental conditions in Kenya with deployed troops.

A recommendation paper will disseminate findings to the DMS and medical community, potentially reducing medication wastage and prompting further research into suitable medications under revised policies.

This contract is for the PhD that the student will be undertaking while conducting the above mentioned research.

Buyer intelligence

Make the case to bid

Reveal who to approach at MINISTRY OF DEFENCE, and generate a go-to-market strategy from their news, accounts and people.

Source & provenance
OCID
3b470e19-df00-4b6e-8d13-1aba9eeb3184
Stage
contract · Contract
Source
Contracts Finder
Buyer ref
71346051
View the original notice on Contracts Finder

Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.

Market context

Who wins this kind of work

The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.

Top suppliers & buyers in Research & Development

Assembling the market network…

MINISTRY OF DEFENCE’s tender network

Assembling the network…

Also open now

Similar open tenders

Medicines Licensing Assessor Services

MHRA

Closes 6 Aug 2026Healthcare
£10.0mValue